Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 6/20 | 0.66 |
| ▸ | DRD3 | P35462 | 6/20 | 0.66 |
| ▸ | DRD4 | P21917 | 2/20 | 0.58 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.58 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 4/20 | 0.55 |
| ▸ | CA2 | P00918 | 4/20 | 0.55 |
| ▸ | ACHE | P22303 | 4/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.52 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL629692 | 1.00 | DRD2 (0.66) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL4001498 | 1.00 | DRD2 (0.66) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL7958191 | 0.93 | DRD2 (0.58) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL8765765 | 0.90 | DRD2 (0.58) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL4000913 | 0.90 | DRD2 (0.58) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL4000915 | 0.90 | DRD2 (0.58) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL23343811 | 0.85 | DRD2 (0.54) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL3961628 | 0.85 | DRD2 (0.54) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL8983525 | 0.81 | DRD2 (0.68) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL10977596 | 0.80 | DRD2 (0.68) | DRD2DRD3DRD4MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050153408-A1 | 7-substituted-2-tetralone or bisulfite adduct is reduced microorganism (Candida) to optically active 7-substituted-2-tetralol;sulfonyl group is introduced to hydroxy group to form optically active 7-substituted-2-sulfonyloxytetralin; nitrogen substituent is introduced via ammonia; industrial scale | KANEKA CORPORATION (JP) | 2005-07-14 | — | — | US | disclosed |
| EP-1457570-A1 | PROCESS FOR PREPARATION OF 2-AMINOTETRALIN DERIVATIVES AND INTERMEDIATES THEREOF | KANEKA CORPORATION (JP) | 2004-09-15 | — | — | EP | disclosed |